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The study was undertaken to evaluate the effect of paracetamol on skeleton in
Wistar rats. The drug was administered orally, once a day, in three doses: P1  3.5
mg/kg, P2  35.0 mg/kg, P3  350.0 mg/kg. The foetuses were delivered by
laparotomy on the 21st day of pregnancy and fixed in alcohol. The skeletons were
stained with alizarin. Insignificant differences of bone malformations were found.
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INTRODUCTION
In reproductive toxicology, as well as in other toxic-
ity studies, various animals and different experimen-
tal methods are used instead of humans. However,
if a hazard is to be detected and the risk for a hu-
man being assessed, then certain experimental con-
ditions must be fulfilled. This is very important espe-
cially for widely used xenobiotics, such as the most
poplar analgesic and antipyretic drug on market
 paracetamol [3].
Several investigators have tested paracetamol for
its effects on the developing organism using it in
vitro and in vivo methods and have reported that
embryotoxicity resulted from the treatment. Neural
tube defects, clef palate and limb abnormalities have
also been observed following the drug-administra-
tion. However, animal data has not been fully con-
firmed in case of humans. Because of numerous neg-
ative findings in humans, paracetamol has been pre-
scribed for pregnant women as a first line painkiller,
which is the safest for the mother and the develop-
ing baby [1,3,10].
The goal of this experiment is to determine if the
congenital malformations caused in rat foetuses are
caused by maternal treatment with paracetamol.
Particular attention is given to the effects on skele-
ton malformations that are very sensitive and com-
mon markers in teratology.
MATERIAL AND METHODS
The whole experiment was based on an animal ex-
perimental model, designed according to WHO tech-
nical direction [15] and the guidelines of the Bioeth-
ical Committee of the Medical University School of
Lublin, Poland.
An experiment was conducted on Wistar breed rats
originally obtained from a commercial breeder (Warsza-
wa-Rembertow, Poland) with initial body weight of 180
– 15 g. The animals were housed in standard labora-
tory cages (max. 5 pieces per cage) at a room temper-
ature of 20 – 3°C on a daylight cycle (7 a.m.7 p.m.).
Standard laboratory fodder (Motycz, Poland) and tap
water were provided ad libitum. Food and water con-
sumption were monitored daily.
Virgin females after two weeks of acclimatisation
period were mated overnight with males of the same
stock. The presence of a vaginal plug or sperm in the
vaginal smear examined the following morning was
taken to indicate successful mating, and the day was
considered as the first day of gestation. The insemi-
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nated animals were randomly gathered in experimen-
tal or control groups with a minimum of 12 in each
group. However, some females were not pregnant
despite the presence of spermatozoa in the smear.
Paracetamol (Sigma, Germany; > 99% purity) was
ground with Tween 80 (Sigma, Germany) and then
diluted in distilled water. The suspension was ad-
ministered orally with the use of a stomach tube,
once a day (between 7.308 a.m.), during days 814
of gestation. Tested substance was given in three
different doses: P1  3.5 mg/kg body weight (p = 8
 number of pregnant female; f = 111  number
of foetuses; s = 66  number of examined alizarin
staining specimens), P2  35.0 mg/kg b.w. (p = 8,
f = 115, s = 75), P3  350.0 mg/kg b.w. (p = 7, f = 95,
s = 70). The treated volumes were proportionate to
the body weight of the animals e.g. 10 ml/kg b.w.
Two control groups were designed: T  the
females received the Tween 80 solution during
the whole second trimester of pregnancy (p = 10,
f = 148, s = 118), K  untreated control (p = 19,
f = 275, s = 176). The animals in group T received
Tween 80 water suspension in volumes correspond-
ing to those given in the treatment groups.
The body weight gain of the dames was moni-
tored on the days 1, 8, 14, and 21 of pregnancy.
All of the animals were killed, by decapitation, on
the 21st day of gestation, and the uterus were deliv-
ered by laparotomy. Foetuses were removed, separat-
ed from placenta, and examined macroscopically for
external malformations. At least 2/3 of the foetuses
from each litter were fixed in 95% ethanol for the
study of the skeleton by single alizarin red S staining
and examined under a stereo-dissection microscope.
Data was statistically analysed using ANOVA [12].
The level of significance was set at p < 0.05 (a = 0.05).
RESULTS
The treated females consumed as much food and
water as the controls and gained comparable weight.
There were no signs of maternal toxicity due to parac-
etamol treatment (data not shown).
There were no statistical differences in foetal
parameters between both control groups (T, K). Be-
cause of this they were united in one pooled control
group (CON) to minimize observation error [4].
The external malformations were not noted in
drug-treated and control groups, except for an in-
significant number of subcutaneous haematomas
which were found on parietal region (K), auricular
cochlea (P2), neck (P1, P2, P3), interscapular region
(P3), lower limb (K, T, P1) and on the mobile part of
the tile (K) (Fig. 1).
The Tables 1 and 2 summarize the frequency and
types of bone malformations observed in paraceta-
mol-treated and controls groups.
The examination of 505 skeletons from both con-
trol and drug treated groups showed a partial ossifi-
cation of the nasal, frontal, parietal, interparietal,
supraoccipital bones. In one the foetuses from the
P2 group, the supraoccipital bone was missing. The
other bones of the skull, including basicranial ones,
did not show any malformation.
The hyoid bone was not observed in two speci-
mens form P2 group as well as in one from the P3
group. Reduction of alizarin staining of the hyoid
bone was found in a single foetus from both control
groups and in two foetuses from P3.
The individual cases of the short 13th ribs were
noted only in both control groups. The wavy 13th
ribs were observed occasionally in all examined
groups, except for P3. Bud and short extra unilat-
eral lumbar ribs were observed in single cases in
untreated control and in the P3 group. One foetus
exposed prenatally to the highest paracetamol dos-
es showed bilateral, well formed short extra lum-
bar ribs.
The appendicular skeleton did not show any
anomalies of the long bones of the upper and low-
er extremities. The unilateral absence of one metac-
arpal bone was observed only in control groups.
Bilateral absence of the first metacarpal bone was
found in all examined groups. One foetus from
group P3 had unilateral missing of the 1st and the
4th metacarpal bones. The 5th metatarsal bone was
not observed in only a few foetuses form all exam-
ined groups.
The sternum, the 5th and/or 6th sternebrae in par-
ticular, was the most common malformed part of
Figure 1. Occurrence of subcutaneous ecchymose in foetuses of
rats treated with paracetamol and in the pooled control groups.
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Table 1. Occurence of skeletal variations (%) in foetuses of rats treated with paracetamol and in the control groups
Control groups Paracetamol-treated groups
T K CON P1 P2 P3
Number of examined 118 176 294 66 75 70
alizarin staining specimens
Nasal, reduced ossification     1 (1.33) 
Frontal, reduced ossification    1 (1.51) 1 (1.33) 
Parietal, reduced ossification 10 (8.47) 9 (5.11) 19 (6.46) 2 (3.03) 8 (10.66) 11 (15.71)
Interparietal, reduced ossification 12 (10.17) 10 (5.68) 22 (7.48) 7 (10.60) 11 (14.66) 13 (18.57)
Supraoccipital, missing     1 (1.33) 
Supraoccipital, reduced ossification 5 (4.24) 5 (2.84) 10 (3.40) 2 (3.03) 3 (4.00) 4 (5.71)
Hyoid, missing     2 (2.66) 1 (1.43)
Hyoid, reduced ossification 1 (0.85) 1 (0.57) 2 (0.68)   2 (2.86)
13th rib, unilateral short 1 (0.85) 1 (0.57) 2 (0.68)   
13th rib, wavy 1 (0.85) 6 (3.40) 7 (2.38) 2 (3.03) 1 (1.33) 
Supernumerary rib, bud unilateral (L1)  1 (0.57) 1 (0.34) 1 (1.51)  3 (4.29)
Supernumerary rib, short unilateral (L1)  1 (0.57) 1 (0.34)   1 (1.43)
Supernumerary rib, short bilateral (L1)      1 (1.43)
Metacarpal, unilateral missing of one bone 2 (1.70) 1 (0.57) 3 (1.02)   
Metacarpal, bilateral missing of one bone 2 (1.70) 2 (1.14) 4 (1.36) 1 (1.51) 2 (2.66) 7 (10.00)
Metacarpal, unilateral missing of two bones      1 (1.43)
Metatarsal, unilateral missing of two bones 4 (3.40) 6 (3.40) 10 (3.40) 3 (4,54) 3 (4.00) 8 (11.43)
Table 2. Occurrence of sternebral variations (%) in foetuses of rats treated with paracetamol and in the control groups
Control groups Paracetamol-treated groups
T K CON P1 P2 P3
Number of examined alizarin staining specimens 118 176 294 66 75 70
6th sternebrae, missing 1 (0.85) 1 (0.57) 2 (0.68) 2 (3.03)  1 (1.43)
6th sternebrae, rudimentary 3 (2.54) 1 (0.57) 4 (1.36)  1 (1.33) 4 (5.71)
6th sternebrae, cleaved  1 (0.57) 1 (0.34)   
6th sternebrae, bifurcated at distal end 1 (0.85)  1 (0.34) 1 (1.51)  
6th sternebrae, reduced ossification 8 (6.78) 12 (6.81) 20 (6.80) 4 (6.06) 10 (13.33) 6 (8.57)
5th sternebrae, missing 1 (0.85)  1 (0.34)  1 (1.33) 2 (2.86)
5th sternebrae, rudimentary 8 (6.78) 13 (7.39) 21 (7.14)  1 (1.33) 2 (2.86)
5th sternebrae, dumbbell-shaped 5 (4.24) 9 (5.11) 14 (4.76) 3 (4.54) 2 (2.66) 3 (4.29)
5th sternebrae, reduced ossification 2 (1.70) 1 (0.57) 3 (1.02) 1 (1.51) 2 (2.66) 3 (4.29)
4th sternebrae, rudimentary 1 (0.85) 1 (0.57) 2 (0.68) 1 (1.51)  
4th sternebrae, dumbbell-shaped     1 (1.33) 2 (2.86)
3rd sternebrae, dumbbell-shaped      1 (1.43)
1st sternebrae, reduced ossification 1 (0.85)  1 (0.34)   
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the skeleton (Fig. 2, 3). The missing, rudimentary and
poorly ossified sternebrae were the most common
observed anomalies. The others malformations such
as bifureated and dumbbell-shaped sternebraes
were seen in control as well as in paracetamol-treat-
ment groups. Only in one case from the untreated
control group the cleavage of the 6th sternebrae
was found.
The mean increment of all bone anomalies was
not statistically different when compared with both
control groups and between drug-treated groups.
DISCUSSION
The result presented above showed that paraceta-
mol did not elevate the skeleton malformations, and
it is well tolerated by foetal and maternal organism.
My previous paper showed that the embryotoxic ef-
fect of a decrease in the foetal body weight was
observed only in group P3 where paracetamol was
administered in the highest dose [2]. However,
Lubawy and Garrett [6] who treated rats with parac-
etamol once a day at doses 125 or 250 mg/kg/day
between days 8 and 14 of the rat pregnancy did not
observe any symptoms of the embryotoxicity. The
lower foetal weight and length were reported after
paracetamol being administered three times a day
at doses 50, 100, 200 mg/kg by Wyskiel [16]. The
placental weight and tail length were increased in
the highest drug-treatment group. The pre- and
postimplantation mortality factors did not differ from
the levels observed in control groups, similarly to the
present study. The spectrum of the bone malforma-
tion was the same as presented in this paper. The
sternum and calvaria bones of the skull were the most
often malformed part of the rat skeleton, but like in
this study the differences were not significant. The
premature closure of the arterial duct, 1.4-hours af-
ter paracetamol administration on the last day of
rats pregnancy and the 40% increase of the cardiac
ventricles volume was also reported [8].
Reproductive, embryo- and foetaltoxicology stud-
ies were also carried out on mice. Reel et al. [11]
reported paracetamol-related decrease of the birth-
weight of the CD mouse. In another study the de-
crease of glutathione concentration in foetal mouse
liver without any malformations related to the parac-
etamol administration between days 6 and 13 of
mouse gestation was distinguished [5].
In vitro studies showed that paracetamol caused
low-level morphological transformations of mouse
embryo cells, but had no adverse effect on the de-
velopment of foetal cultured salivary glands [7,9].
The malformations were observed when paraceta-
mol was added to the cultured rat embryos at doses
Figure 2. Sternum of rat foetus on gestation day 21 in alizarin
red-S staining. Cleaved 6th sternebrae (long arrow) and symmet-
rically dumbbell-shaped 5th sternebrae (short arrow).
Figure 3. Sternum of rat foetus on gestation day 21 in alizarin
red-S staining. Poorly ossified, bifurcated at distal end 6th sterne-
brae (long arrow) and asymmetrically dumbbell-shaped 5th
sternebrae (short arrow).
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50 mg/l. Neural defects, such as abnormal closure
of the anterior neuropores were increased when
paracetamol or its mixture with 3-hydroxy metabo-
lite was added to the medium but not when parac-
etamol was administered by an intra-amniotic injec-
tion [13]. The principal role in paracetamol embryo-
toxicity is related to the toxic effect of its metabolites.
Its embryotoxicity increased when glutathione syn-
thesis was inhibited with buthionine sulphoximine
and decreased when glutatione synthesis was stim-
ulated with N-acetylcysteine.
The big, epidemiological, human studies showed
good paracetamol tolerability [1,3]. However, a few
case reports presented a possible association with
gastroshisis and congenital dislocations of the hip
[14]. Generally, paracetamol is considered a safe drug
during pregnancy for both mother and child.
Based on the results of this study, I confirm that
paracetamol did not delay the ossificaion of foetal
bones. However, other studies, especially neurotox-
icological and behavioural ones, are needed to
proove good prenatal tolerability of this drug.
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